We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$19B
AUM Growth
+$4.37B
Cap. Flow
+$3.05B
Cap. Flow %
16.07%
Top 10 Hldgs %
39.91%
Holding
1,362
New
110
Increased
730
Reduced
452
Closed
64

Sector Composition

Rank Sector Weight
1 Technology 35.28%
2 Financials 15.39%
3 Healthcare 5.04%
4 Energy 4.05%
5 Consumer Discretionary 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLAB icon
601
Silicon Laboratories
SLAB
$7.17B
$2.34M 0.01%
11,348
-14,150
-55% -$2.61M
ERII icon
602
Energy Recovery
ERII
$446M
$2.34M 0.01%
108,698
-61,177
-36% -$1.28M
VMW
603
DELISTED
VMware, Inc
VMW
$2.34M 0.01%
20,162
-457
-2% -$60.1K
ISBC
604
DELISTED
Investors Bancorp, Inc.
ISBC
$2.32M 0.01%
152,840
-76,239
-33% -$1.17M
LAZ icon
605
Lazard
LAZ
$4.13B
$2.3M 0.01%
52,767
+4,737
+10% +$222K
FFIN icon
606
First Financial Bankshares
FFIN
$5.04B
$2.3M 0.01%
45,248
-7,771
-15% -$395K
ALXO icon
607
ALX Oncology
ALXO
$261M
$2.3M 0.01%
+106,980
New +$4.61M
RDUS
608
DELISTED
Radius Health, Inc.
RDUS
$2.29M 0.01%
330,394
+251,374
+318% +$3.69M
OCFT
609
DELISTED
OneConnect Financial Technology
OCFT
$2.28M 0.01%
92,219
+65,245
+242% +$1.93M
ADAP
610
DELISTED
Adaptimmune Therapeutics
ADAP
$2.27M 0.01%
606,763
-134,152
-18% -$611K
KRYS icon
611
Krystal Biotech
KRYS
$10.1B
$2.27M 0.01%
32,493
+9,239
+40% +$538K
ROCC
612
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$2.27M 0.01%
+84,262
New +$2.48M
YELP icon
613
Yelp
YELP
$1.45B
$2.26M 0.01%
62,352
-20,954
-25% -$787K
LPX icon
614
Louisiana-Pacific
LPX
$5.06B
$2.26M 0.01%
28,794
-1,848
-6% -$127K
STEM icon
615
Stem
STEM
$48.4M
$2.24M 0.01%
+5,901
New +$2.56M
AJRD
616
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$2.24M 0.01%
47,815
-4,167
-8% -$183K
MASS icon
617
908 Devices
MASS
$329M
$2.23M 0.01%
86,259
+5,641
+7% +$166K
AXS icon
618
AXIS Capital
AXS
$7.68B
$2.23M 0.01%
40,855
+3,676
+10% +$190K
ZD icon
619
Ziff Davis
ZD
$1.96B
$2.22M 0.01%
20,020
-4,266
-18% -$506K
CRSP icon
620
CRISPR Therapeutics
CRSP
$4.73B
$2.22M 0.01%
29,264
+727
+3% +$63.5K
EXP icon
621
Eagle Materials
EXP
$6.29B
$2.22M 0.01%
13,311
-166
-1% -$25.5K
NKLA
622
DELISTED
Nikola Corporation Common Stock
NKLA
$2.22M 0.01%
7,484
+960
+15% +$320K
ADEA icon
623
Adeia
ADEA
$2.94B
$2.2M 0.01%
440,083
-134,224
-23% -$668K
AMTX icon
624
Aemetis
AMTX
$106M
$2.2M 0.01%
+178,599
New +$3.15M
AI icon
625
C3.ai
AI
$1.43B
$2.19M 0.01%
+70,047
New +$2.84M

Similar funds

Rafferty Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Rafferty Asset Management held 1,362 positions worth $19B, up 30% from $14.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rafferty Asset Management deployed $3.05B of net new capital in Q4 2021, opening 110 new positions and adding to 730 existing holdings. Its largest new stake was Aflac: 345,009 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $81.8M trimmed.

  • Rafferty Asset Management's largest Q4 2021 buy was Aflac: 345,009 shares worth $20.1M.
  • Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $492M increase.
  • Rafferty Asset Management's biggest Q4 2021 reduction was VanEck Gold Miners ETF, cutting an estimated $81.8M.
  • Rafferty Asset Management fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $8.07M.
  • Rafferty Asset Management's ten largest holdings make up 40% of its $19B portfolio in Q4 2021.
  • Rafferty Asset Management opened 110 new positions and closed 64 in Q4 2021.
  • Rafferty Asset Management's portfolio value rose 30% quarter-over-quarter to $19B.

Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.